Cargando…
Next-generation metabolomics in lung cancer diagnosis, treatment and precision medicine: mini review
Lung cancer is the leading cause of cancer-related death. Next-generation metabolomics is becoming a powerful emerging technology for studying the systems biology and chemistry of health and disease. This mini review summarized the main platforms of next-generation metabolomics and its main applicat...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5777812/ https://www.ncbi.nlm.nih.gov/pubmed/29383200 http://dx.doi.org/10.18632/oncotarget.22404 |
_version_ | 1783294253931167744 |
---|---|
author | Yu, Li Li, Kefeng Zhang, Xiaoye |
author_facet | Yu, Li Li, Kefeng Zhang, Xiaoye |
author_sort | Yu, Li |
collection | PubMed |
description | Lung cancer is the leading cause of cancer-related death. Next-generation metabolomics is becoming a powerful emerging technology for studying the systems biology and chemistry of health and disease. This mini review summarized the main platforms of next-generation metabolomics and its main applications in lung cancer including early diagnosis, pathogenesis, classifications and precision medicine. The period covers between 2009 and August, 2017. The major issues and future directions of metabolomics in lung cancer research and clinical applications were also discussed. |
format | Online Article Text |
id | pubmed-5777812 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Impact Journals LLC |
record_format | MEDLINE/PubMed |
spelling | pubmed-57778122018-01-30 Next-generation metabolomics in lung cancer diagnosis, treatment and precision medicine: mini review Yu, Li Li, Kefeng Zhang, Xiaoye Oncotarget Review Lung cancer is the leading cause of cancer-related death. Next-generation metabolomics is becoming a powerful emerging technology for studying the systems biology and chemistry of health and disease. This mini review summarized the main platforms of next-generation metabolomics and its main applications in lung cancer including early diagnosis, pathogenesis, classifications and precision medicine. The period covers between 2009 and August, 2017. The major issues and future directions of metabolomics in lung cancer research and clinical applications were also discussed. Impact Journals LLC 2017-11-11 /pmc/articles/PMC5777812/ /pubmed/29383200 http://dx.doi.org/10.18632/oncotarget.22404 Text en Copyright: © 2017 Yu et al. http://creativecommons.org/licenses/by/3.0/ This article is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/) (CC-BY), which permits unrestricted use and redistribution provided that the original author and source are credited. |
spellingShingle | Review Yu, Li Li, Kefeng Zhang, Xiaoye Next-generation metabolomics in lung cancer diagnosis, treatment and precision medicine: mini review |
title | Next-generation metabolomics in lung cancer diagnosis, treatment and precision medicine: mini review |
title_full | Next-generation metabolomics in lung cancer diagnosis, treatment and precision medicine: mini review |
title_fullStr | Next-generation metabolomics in lung cancer diagnosis, treatment and precision medicine: mini review |
title_full_unstemmed | Next-generation metabolomics in lung cancer diagnosis, treatment and precision medicine: mini review |
title_short | Next-generation metabolomics in lung cancer diagnosis, treatment and precision medicine: mini review |
title_sort | next-generation metabolomics in lung cancer diagnosis, treatment and precision medicine: mini review |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5777812/ https://www.ncbi.nlm.nih.gov/pubmed/29383200 http://dx.doi.org/10.18632/oncotarget.22404 |
work_keys_str_mv | AT yuli nextgenerationmetabolomicsinlungcancerdiagnosistreatmentandprecisionmedicineminireview AT likefeng nextgenerationmetabolomicsinlungcancerdiagnosistreatmentandprecisionmedicineminireview AT zhangxiaoye nextgenerationmetabolomicsinlungcancerdiagnosistreatmentandprecisionmedicineminireview |